Acute flaccid myelitis: not uncommon in rural Uganda?
Uganda
acute flaccid myelitis
poliomyelitis
sub-Saharan Africa
Journal
Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
03
2023
revised:
01
07
2023
accepted:
13
10
2023
medline:
20
10
2023
pubmed:
20
10
2023
entrez:
20
10
2023
Statut:
epublish
Résumé
Acute Flaccid Myelitis is a paralytic illness with significant similarities to poliomyelitis, and which affects predominantly children. It was first fully delineated only in 2014 in the USA, occurring in epidemic clusters with a likely overall increasing incidence. It has subsequently rapidly been identified in Europe, the UK, and Australasia and the Far East, confirming it to be an emerging, global, infectious neurological disease. It has, however, been very little studied in low- and middle-income countries-reflecting partly of the global imbalance in science and medical research, and partly the extremely low provision of neurological care in most low- and middle-income countries: Uganda currently has no specialized neurology services outside the capital Kampala. During extended visits over a 2-year period with involvement in acute adult and paediatric internal medicine, one of us (NS) encountered at least six new patients with acute flaccid myelitis, suggesting that both the geographical reach and the frequency of the disorder may be significantly greater than previously thought. Here, these cases are described together with their clinical features and, where available, course and (limited) investigation results. These observations have significant implications concerning the current, and potentially the future geographical spread of the disease, and its clinical phenomenology. In addition, they highlight serious problems concerning the global applicability of the current Acute Flaccid Myelitis diagnostic criteria.
Identifiants
pubmed: 37860825
doi: 10.1093/braincomms/fcad246
pii: fcad246
pmc: PMC10584080
doi:
Types de publication
Journal Article
Langues
eng
Pagination
fcad246Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.
Déclaration de conflit d'intérêts
None of the authors has any competing interests to declare.
Références
Euro Surveill. 2016;21(4):
pubmed: 26848143
Pediatr Infect Dis J. 2019 Jan;38(1):16-21
pubmed: 30234793
J Trop Pediatr. 2019 Aug 1;65(4):309-314
pubmed: 30169722
Euro Surveill. 2019 Feb;24(6):
pubmed: 30755296
Eur J Neurol. 2017 Aug;24(8):1077-1083
pubmed: 28639345
J Neurol Sci. 2006 Jul 15;246(1-2):59-64
pubmed: 16542684
Pediatr Neurol. 2016 Feb;55:17-21
pubmed: 26621554
Ann Neurol. 2016 Sep;80(3):326-38
pubmed: 27422805
Euro Surveill. 2022 Oct;27(42):
pubmed: 36268734
J Paediatr Child Health. 2018 Mar;54(3):247-253
pubmed: 28960591
J Neurol Sci. 2006 Aug 15;247(1):29-34
pubmed: 16624322
Lancet. 2021 Jan 23;397(10271):334-346
pubmed: 33357469
Rev Soc Bras Med Trop. 2020 Nov 13;54:e20200259
pubmed: 33206882
Clin Infect Dis. 2018 Feb 10;66(5):653-664
pubmed: 29028962
Nature. 2022 Apr 27;:
pubmed: 35478022
Emerg Infect Dis. 2020 Feb;26(2):
pubmed: 31961305